Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hedgehog acyltransferase-like protein (HHATL) is a human protein coded by the HHATL gene, located on chromosome 3. It is part of the membrane-bound O-acyltransferase (MBOAT) superfamily. Unlike its better-characterized relative Hedgehog acyltransferase (HHAT), HHATL does not itself exhibit enzymatic activity in palmitoylating Hedgehog proteins. Instead, HHATL negatively regulates the N-terminal palmitoylation of Sonic Hedgehog (SHH) by interacting with HHAT, thereby acting as a modulator of the Hedgehog signaling pathway[3]. Additionally, HHATL has been shown to ameliorate endoplasmic reticulum stress via the activation of autophagy, through interactions with the protein LC3[4]. The physiological and pathological roles of HHATL remain under investigation, with no current confirmation as a direct therapeutic target or biomarker. Alternative names for HHATL include C3orf3, GUP1, MBOAT3, and other synonyms relevant to its sequence homology and proposed functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hedgehog acyltransferase-like protein (HHATL).